BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20824766)

  • 1. The PREHAMI (PREsillion™ in high-risk acute myocardial infarction) registry: in-hospital and long-term outcomes.
    Sciahbasi A; Pendenza G; Romagnoli E; Summaria F; Patrizi R; Lucci V; Giannico MB; Penco M; Lioy E
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):608-14. PubMed ID: 20824766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
    Lim SY; Park HW; Chung WY; Kim SY; Kim KS; Bae JW; Youn TJ;
    J Invasive Cardiol; 2012 Jun; 24(6):270-3. PubMed ID: 22684380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group.
    Brodie BR; Stuckey T; Downey W; Humphrey A; Nussbaum M; Laurent S; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):893-900. PubMed ID: 19016465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: rationale and safety.
    Prasad SB; David T; Malaiapan Y; Cameron JD; Meredith IT
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):193-200. PubMed ID: 20549694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
    Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
    JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
    Spaulding C; Teiger E; Commeau P; Varenne O; Bramucci E; Slama M; Beatt K; Tirouvanziam A; Polonski L; Stella PR; Clugston R; Fajadet J; de Boisgelin X; Bode C; Carrié D; Erglis A; Merkely B; Hosten S; Cebrian A; Wang P; Stoll HP; Henry P
    JACC Cardiovasc Interv; 2011 Jan; 4(1):14-23. PubMed ID: 21251624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry.
    Manari A; Ortolani P; Guastaroba P; Marzaroli P; Menozzi M; Magnavacchi P; Varani E; Vignali L; Campo G; Marzocchi A
    J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):102-9. PubMed ID: 20814313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.
    Romano M; Buffoli F; Tomasi L; Corrado L; Ferrari MR; Zanini R
    Catheter Cardiovasc Interv; 2008 May; 71(6):759-63. PubMed ID: 18412066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up.
    Bystroň M; Cervinka P; Spaček R; Kvašňák M; Jakabčin J; Cervinková M; Kala P; Widimský P
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):627-31. PubMed ID: 20506282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.
    Burzotta F; Trani C; Todaro D; Mazzari MA; Porto I; De Vita M; Brugaletta S; Coroleu SF; Niccoli G; Leone AM; Giammarinaro M; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):457-65. PubMed ID: 19229977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
    Angioi M; Barragan P; Cattan S; Collet F; Dupouy P; Durand P; Fajadet J; Finet G; Gerardin B; Gommeaux A; Karsenty B; Loubeyre C; Meyer P; Morice MC; Moulichon MÉ; Sayah S; Silvestri M; Tabone X; Unterseeh T; Wittenberg O; Lablanche JM
    Arch Cardiovasc Dis; 2012 Feb; 105(2):60-7. PubMed ID: 22424323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of direct versus conventional stenting in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Isik T; Ayhan E; Uyarel H; Ergelen M; Cicek G; Osmonov D; Turkkan C; Turer A; Ghannadian B; Eren M
    Coron Artery Dis; 2012 Aug; 23(5):348-53. PubMed ID: 22566098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Maluenda G; Lemesle G; Ben-Dor I; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):86-92. PubMed ID: 19670305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.